Suchergebnisse - "Pinato, David J"

PubPharm (8)

1

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

2

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

3

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

4

Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Pinato, D. | Fessas, P. | Sapisochin, G. | +1

5

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma : A Response-Based Approach

enthalten in: Hepatology (Baltimore, Md.) | 2020

von Han, G. | Berhane, S. | Toyoda, H. | +31

6

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Flynn, M. | Sayed, A. | Sharma, R. | +2

7

Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Cortes, E. | Lachowski, D. | Rice, A. | +8

CommentIn: Hepatology. 2019 Feb;69(2):484-486. - PMID 30284734

8

Breaking Kuhn's paradigm in advanced hepatocellular carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Pinato, D.

CommentOn: Hepatology. 2018 May;67(5):1784-1796. - PMID 29159910

1
[1]